BMY vs NVO
Bristol Myers Squibb vs Novo Nordisk A/S — AI-powered side-by-side comparison
| Metric | BMY | NVO |
|---|---|---|
| AI Score | 71 | 53 |
| Price | $57.70 | $48.88 |
| P/E Ratio | 19.93× | 11.67× |
| ROE | 41.6% | 66.4% |
| Revenue Growth YoY | 1.8% | 8.1% |
| Gross Margin | 53.7% | 81.8% |
| Debt / Equity | 2.44× | 0.67× |
| Dividend Yield | 4.3% | 3.6% |
| RSI (14) | 54.4 | 61.1 |
| Beta | 0.235 | 1.8569 |
| Expected Upside | +4.7% | +27.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
NVO Full Analysis